Chemical biology, molecular mechanism and clinical perspective of 
gamma-secretase modulators in Alzheimer's disease

Bulic, Bruno; Ness, Julia; Hahn, Stefanie; Rennhack, Andreas; Jumpertz, Thorsten; Weggen, Sascha

doi:10.2174/157015911798376352

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Chemical biology, molecular mechanism and clinical perspective of gamma-secretase modulators in Alzheimer's disease

MPS-Authors

Bulic, Bruno
Center of Advanced European Studies and Research (caesar), Max Planck Society;

External Resource

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391656/
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Bulic, B., Ness, J., Hahn, S., Rennhack, A., Jumpertz, T., & Weggen, S. (2011). Chemical biology, molecular mechanism and clinical perspective of gamma-secretase modulators in Alzheimer's disease. Current Neuropharmacology, 9(4), 598-622. doi:10.2174/157015911798376352.

Cite as: https://hdl.handle.net/21.11116/0000-0009-4A88-B

Abstract

There is no abstract available